P&G UVA data
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble plans to submit additional UVA efficacy data to FDA by June 1 in support of its petition to include the use of avobenzone in combination with zinc oxide or phenylbenzimidazole sulfonic acid in the final sunscreen monograph, the company tells FDA in an April 20 letter. P&G had submitted safety data on the ingredient combinations Feb. 26 following a request from the agency during an Jan. 27 "feedback" meeting ("The Tan Sheet" March 15, In Brief). FDA deemed the data "insufficient" in an April 8 letter to P&G ("The Tan Sheet" April 26, p. 9)